iSCLife-MDS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iSCLife-MDS, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]